Cargando…

Use of Glucagon in Patients With Type 1 Diabetes

IN BRIEF Glucagon is an invaluable tool for patients with type 1 diabetes who experience severe hypoglycemia, but little is known about the actual use of rescue glucagon in this patient population. This survey study found that patients with type 1 diabetes were not adequately prescribed glucagon or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haymond, Morey W., Liu, Jingwen, Bispham, Jeoffrey, Hickey, Aileen, McAuliffe-Fogarty, Alicia H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2019
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468823/ https://www.ncbi.nlm.nih.gov/pubmed/31057222 http://dx.doi.org/10.2337/cd18-0028

Ejemplares similares

Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes
por: Hughes, Allyson S., et al.
Publicado: (2023)

“I Live in Constant Fear of Highs,” the Daily Impact of Type 1 Diabetes
por: Hughes, Allyson S, et al.
Publicado: (2020)

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey
por: Liu, Jingwen, et al.
Publicado: (2020)

“It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes
por: Hughes, Allyson S., et al.
Publicado: (2022)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?
por: Aroda, Vanita R., et al.
Publicado: (2018)

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study
por: Polonsky, William, et al.
Publicado: (2021)

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes—So Why Is Their Uptake So Low?
por: King, Aaron, et al.
Publicado: (2023)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
por: Shaefer, Charles F.
Publicado: (2016)

Using Photography as a Method to Explore Adolescent Challenges and Resilience in Type 1 Diabetes
por: Walker, Ashby F., et al.
Publicado: (2015)

Stigma in People With Type 1 or Type 2 Diabetes
por: Liu, Nancy F., et al.
Publicado: (2017)

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
por: Lang, Benjamin, et al.
Publicado: (2018)

The Nature and Meaning of Insulin Pump Use in Emerging Adults With Type 1 Diabetes
por: Hood, Donna G., et al.
Publicado: (2015)

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know
por: Skolnik, Neil, et al.
Publicado: (2018)

Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
por: Liu, Jingwen, et al.
Publicado: (2023)

Disparities in Social Support Systems for Youths With Type 1 Diabetes
por: Walker, Ashby F., et al.
Publicado: (2015)

Personalizing Type 2 Diabetes Management: Use of a Patient-Centered Approach to Individualizing A1C Goals and Pharmacological Regimens
por: Lahiri, Sharon W.
Publicado: (2017)

Correlations Between A1C and Diabetes Knowledge, Diabetes Numeracy, and Food Security in a Vulnerable Type 2 Diabetes Population
por: Young, Clipper F., et al.
Publicado: (2018)

Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
por: Wysham, Carol H., et al.
Publicado: (2018)

Reasons for Open and Closed Attitudes Regarding Type 1 Diabetes
por: Easler, Jamie K., et al.
Publicado: (2018)

Perceptions of Adolescent Patients of the “Lived Experience” of Type 1 Diabetes
por: King, Kathryn M., et al.
Publicado: (2017)

Troponin T and Pro–B-Type Natriuretic Peptide in Fetuses of Type 1 Diabetic Mothers
por: Russell, Noirin E., et al.
Publicado: (2009)

“Diabetes Just Tends to Take Over Everything”: Experiences of Support and Barriers to Diabetes Management for Pregnancy in Women With Type 1 Diabetes
por: Singh, Harsimran, et al.
Publicado: (2019)

Focus on the Positive: A Qualitative Study of Positive Experiences Living With Type 1 or Type 2 Diabetes
por: Carrier, Molly A., et al.
Publicado: (2021)

Group Versus Individual Diabetes Education for Persons With Experience of Homelessness in Canada
por: McSweeney, Breanna, et al.
Publicado: (2023)

Diabetes Numeracy and Blood Glucose Control: Association With Type of Diabetes and Source of Care
por: Zaugg, Stephanie D., et al.
Publicado: (2014)

Revising the Diabetes Distress Scale for Use Among Adults in the Dominican Republic: Findings From Cognitive Interviews
por: Wallace, Deshira D., et al.
Publicado: (2022)

Lessons Learned From a Life With Type 1 Diabetes: Adult Perspectives
por: Freeborn, Donna, et al.
Publicado: (2017)

Young Adults With Type 1 Diabetes: Romantic Relationships and Implications for Well-Being
por: Helgeson, Vicki S.
Publicado: (2017)

Exploring the Burden of Mealtime Insulin Dosing in Adults and Children With Type 1 Diabetes
por: Lane, Wendy, et al.
Publicado: (2021)

Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes
por: Pratley, Richard E., et al.
Publicado: (2017)

Factors Considered Important by Healthcare Professionals for the Management of Using Complementary Therapy in Diabetes: A Text-Mining Analysis
por: Chang, Hsiao-Yun, et al.
Publicado: (2022)

Feasibility of Parent-to-Parent Support in Recently Diagnosed Childhood Diabetes: The PLUS Study
por: Channon, Sue, et al.
Publicado: (2016)

Factors Associated With Improved A1C Among Adults With Type 1 Diabetes in the United States
por: Akturk, Halis K., et al.
Publicado: (2023)

Recruitment and Retention of Asian Americans in Web-Based Physical Activity Promotion Programs: A Discussion Paper
por: Chee, Wonshik, et al.
Publicado: (2019)

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2016)

Feasibility of the SMART Project: A Text Message Program for Adolescents With Type 1 Diabetes
por: Herbert, Linda Jones, et al.
Publicado: (2014)

Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults With Type 1 Diabetes and Coronavirus Disease 2019
por: Miyazaki, Brian, et al.
Publicado: (2023)

Factors Associated With Achieving Target A1C in Children and Adolescents With Type 1 Diabetes: Findings From the T1D Exchange Quality Improvement Collaborative
por: Demeterco-Berggren, Carla, et al.
Publicado: (2023)

Revision and Psychometric Evaluation of the Diabetes Knowledge Questionnaire for People With Type 2 Diabetes
por: Zuñiga, Julie A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nt45jflltirbk8lus0s28m2fig